Company Search:
Advanced Search
Sponsored Links
Erytech Pharma SA Company Snapshot
Erytech Pharma SA operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other pharmaceutical manufacturers in Europe: CO.DON AG of Germany (2018 sales of 5.65 million Euro [US$6.32 million] of which 100% was Product sales), Medincell SA (6.44 million Euro [US$7.19 million] ), and Curasan AG which is based in Germany (5.84 million Euro [US$6.53 million] ).

Sales Analysis. During the year ended December of 2018, sales at Erytech Pharma SA were 4.45 million Euro (US$4.97 million). This is an increase of 32.2% versus 2017, when the company's sales were 3.36 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Erytech Pharma SA
  Stock Performance Chart for Erytech Pharma SA
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 3.83
(Figures in Euro)
1 Week 3.8%   13 Weeks -20.1%  
4 Weeks -37.3%   52 Weeks -45.6%  
Erytech Pharma SA Key Data:
  Ticker: ERYP Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 4,447,000
(Year Ending Jan 2019).
Employees: 172
  Currency: Euro Market Cap: 68,611,071
  Fiscal Yr Ends: December Shares Outstanding: 17,937,535
  Share Type: Actions Ordinaires Closely Held Shares: 451,794
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.